Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients with inborn errors of immunity (IEI) showed a similar infection-fatality rate, a lower incidence in pediatric age, and a younger age at death than the SARS-CoV-2–positive Italian population. The fatality rate was lower than previously reported from other IEI cohorts. Antibody deficiencies showed a long-lasting SARS-CoV-2 positivity.
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity / Milito, C., Lougaris, V., Giardino, G., Punziano, A., Vultaggio, A., Carrabba, M., Cinetto, F., Scarpa, R., Delle Piane, R.M., Baselli, L., Ricci, S., Rivalta, B., Conti, F., Marasco, C., Marzollo, A., Firinu, D., Pulvirenti, F., Lagnese, G., Vivarelli, E., Cancrini, C., et al.. - In: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE. - ISSN 2213-2198. - 9:7(2021), pp. 2904-2906.e2. [10.1016/j.jaip.2021.04.017]
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity
Milito C.;Quinti I.
2021
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients with inborn errors of immunity (IEI) showed a similar infection-fatality rate, a lower incidence in pediatric age, and a younger age at death than the SARS-CoV-2–positive Italian population. The fatality rate was lower than previously reported from other IEI cohorts. Antibody deficiencies showed a long-lasting SARS-CoV-2 positivity.| File | Dimensione | Formato | |
|---|---|---|---|
|
Milito_Clinical-outcome_2021.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
570.86 kB
Formato
Adobe PDF
|
570.86 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
